NIH & Moderna Partnership/ Royalty Document
National Institute of Allergy and Infectious Diseases (NIAID) is a component of the National Institutes of Health (NIH) and agency of the Department of Health and Human Services. NIH receives royalties from the vaccine companies for patents it has created using tax dollars managed by Anthony Fauci.
Excerpt from the document below:
4. ROYALTIES The Licensee agrees to pay the NIAID a non-creditable, nonrefundable license issue royalty as set forth in Appendix C.
4.2 The Licensee agrees to pay the NIAID a nonrefundable annual royalty as set forth in Appendix C.
4.3 All royalties due under this Agreement shall be paid in U.S. dollars, net of all non? U3. taxes, and payment options are listed in Appendix E. For conversion of foreign currency to US. dollars. the conversion rate shall be the New York foreign exchange rate quoted in The Wall Street Journal on the day that the payment is due.
4.4 Additional royalties may be assessed by the NIAID on any payment that is more than ninety days overdue at the rate of one percent per month. This one percent per month rate may be applied retroactively from the original due date until the date of receipt by the NIAID of the overdue payment and additional royalties. The payment of any additional royalties shall not prevent the NIAID from exercising any other rights it may have as a consequence ofthe lateness of any payment.
NIH-Moderna-Confidential-Agreements (Search “Royalties”)
The NIH claims joint ownership of Moderna’s coronavirus vaccine